Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trialsGeert D’Haens, Marc Ferrante, Tadakazu Hisamatsu et al.|The Lancet|2022Cited by 383
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trialMarc Ferrante, Geert D’Haens, Remo Panaccione et al.|The Lancet|2022Cited by 312
The Slingshot Family of Phosphatases Mediates Rac1 Regulation of Cofilin Phosphorylation, Laminin-332 Organization, and Motility Behavior of KeratinocytesKristina Kligys, Jonathan Jones|Journal of Biological Chemistry|2007Cited by 92
α6β4 Integrin, a Master Regulator of Expression of Integrins in Human KeratinocytesKristina Kligys, Jonathan Jones|Journal of Biological Chemistry|2012Cited by 51